These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

961 related items for PubMed ID: 9173910

  • 41. Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain.
    Harigaya Y, Saido TC, Eckman CB, Prada CM, Shoji M, Younkin SG.
    Biochem Biophys Res Commun; 2000 Sep 24; 276(2):422-7. PubMed ID: 11027491
    [Abstract] [Full Text] [Related]

  • 42. Amyloid load and neural elements in Alzheimer's disease and nondemented individuals with high amyloid plaque density.
    Mochizuki A, Peterson JW, Mufson EJ, Trapp BD.
    Exp Neurol; 1996 Nov 24; 142(1):89-102. PubMed ID: 8912901
    [Abstract] [Full Text] [Related]

  • 43. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R, Hockey A, Montgomery P, Beyreuther K, Masters CL.
    N Engl J Med; 1989 Jun 01; 320(22):1446-52. PubMed ID: 2566117
    [Abstract] [Full Text] [Related]

  • 44. Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans.
    DeKosky ST, Abrahamson EE, Ciallella JR, Paljug WR, Wisniewski SR, Clark RS, Ikonomovic MD.
    Arch Neurol; 2007 Apr 01; 64(4):541-4. PubMed ID: 17420316
    [Abstract] [Full Text] [Related]

  • 45. Evidence of amyloid beta-protein immunoreactive early plaque lesions in Down's syndrome brains.
    Ikeda S, Yanagisawa N, Allsop D, Glenner GG.
    Lab Invest; 1989 Jul 01; 61(1):133-7. PubMed ID: 2473275
    [Abstract] [Full Text] [Related]

  • 46. Down syndrome and Alzheimer disease.
    Hyman BT.
    Prog Clin Biol Res; 1992 Jul 01; 379():123-42. PubMed ID: 1409740
    [Abstract] [Full Text] [Related]

  • 47. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
    Attems J, Lintner F, Jellinger KA.
    Acta Neuropathol; 2004 Apr 01; 107(4):283-91. PubMed ID: 14986026
    [Abstract] [Full Text] [Related]

  • 48. Increased serum neopterin levels in adults with Down syndrome.
    Mehta PD, Patrick BA, Dalton AJ, Patel B, Mehta SP, Pirttila T, Coyle PK.
    J Neuroimmunol; 2005 Jul 01; 164(1-2):129-33. PubMed ID: 15908015
    [Abstract] [Full Text] [Related]

  • 49. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
    Baum L, Chen L, Ng HK, Pang CP.
    Microsc Res Tech; 2000 Aug 15; 50(4):278-81. PubMed ID: 10936880
    [Abstract] [Full Text] [Related]

  • 50. Down syndrome and Alzheimer's disease: a link between development and aging.
    Lott IT, Head E.
    Ment Retard Dev Disabil Res Rev; 2001 Aug 15; 7(3):172-8. PubMed ID: 11553933
    [Abstract] [Full Text] [Related]

  • 51. A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain.
    Czasch S, Paul S, Baumgärtner W.
    Neurobiol Aging; 2006 Feb 15; 27(2):293-305. PubMed ID: 16002188
    [Abstract] [Full Text] [Related]

  • 52. Variability and heterogeneity in Alzheimer's disease with cotton wool plaques: a clinicopathological study of four autopsy cases.
    Yokota O, Terada S, Ishizu H, Ujike H, Ishihara T, Namba M, Hayashi Y, Nishinaka T, Namba R, Nakashima H, Uéda K, Checler F, Kuroda S.
    Acta Neuropathol; 2003 Oct 15; 106(4):348-56. PubMed ID: 12883830
    [Abstract] [Full Text] [Related]

  • 53. Neuritic involvement within bFGF immunopositive plaques of Alzheimer's disease.
    Cummings BJ, Su JH, Cotman CW.
    Exp Neurol; 1993 Dec 15; 124(2):315-25. PubMed ID: 8287930
    [Abstract] [Full Text] [Related]

  • 54. Secondary deposition of beta amyloid within extracellular neurofibrillary tangles in Alzheimer-type dementia.
    Yamaguchi H, Nakazato Y, Shoji M, Okamoto K, Ihara Y, Morimatsu M, Hirai S.
    Am J Pathol; 1991 Mar 15; 138(3):699-705. PubMed ID: 1705753
    [Abstract] [Full Text] [Related]

  • 55. Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid.
    Wisniewski T, Golabek A, Matsubara E, Ghiso J, Frangione B.
    Biochem Biophys Res Commun; 1993 Apr 30; 192(2):359-65. PubMed ID: 8484748
    [Abstract] [Full Text] [Related]

  • 56. Alzheimer's amyloid precursor protein-positive degenerative neurites exist even within kuru plaques not specific to Alzheimer's disease.
    Ohgami T, Kitamoto T, Weidmann A, Beyreuther K, Tateishi J.
    Am J Pathol; 1991 Dec 30; 139(6):1245-50. PubMed ID: 1684265
    [Abstract] [Full Text] [Related]

  • 57. The involvement of amyloid associated proteins in the formation of beta-protein filaments in Alzheimer's disease.
    Potter H, Ma J, Das S, Kayyali U.
    Prog Clin Biol Res; 1994 Dec 30; 390():57-71. PubMed ID: 7724651
    [No Abstract] [Full Text] [Related]

  • 58. Selective binding of soluble Abeta1-40 and Abeta1-42 to a subset of senile plaques.
    Prior R, D'Urso D, Frank R, Prikulis I, Cleven S, Ihl R, Pavlakovic G.
    Am J Pathol; 1996 Jun 30; 148(6):1749-56. PubMed ID: 8669461
    [Abstract] [Full Text] [Related]

  • 59. Dystrophic neurite formation associated with age-related beta amyloid deposition in the neocortex: clues to the genesis of neurofibrillary pathology.
    Vickers JC, Chin D, Edwards AM, Sampson V, Harper C, Morrison J.
    Exp Neurol; 1996 Sep 30; 141(1):1-11. PubMed ID: 8797662
    [Abstract] [Full Text] [Related]

  • 60. P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain.
    Higgins LS, Murphy GM, Forno LS, Catalano R, Cordell B.
    Am J Pathol; 1996 Aug 30; 149(2):585-96. PubMed ID: 8701997
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 49.